These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 20134196

  • 21. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y.
    Neurology; 2010 Jul 20; 75(3):208-16. PubMed ID: 20644148
    [Abstract] [Full Text] [Related]

  • 22. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.
    Semin Ophthalmol; 2008 Jul 20; 23(3):191-200. PubMed ID: 18432545
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. NMO-IgG and Devic's neuromyelitis optica: a French experience.
    Marignier R, De Sèze J, Vukusic S, Durand-Dubief F, Zéphir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C.
    Mult Scler; 2008 May 20; 14(4):440-5. PubMed ID: 18208892
    [Abstract] [Full Text] [Related]

  • 26. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
    Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP.
    J Neurol Sci; 2010 Apr 15; 291(1-2):52-6. PubMed ID: 20117794
    [Abstract] [Full Text] [Related]

  • 27. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S.
    Biochem Biophys Res Commun; 2009 Sep 04; 386(4):623-7. PubMed ID: 19545538
    [Abstract] [Full Text] [Related]

  • 28. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L, Fernández JM, Rivarola V, Di Giusto G, Ford P, Villa A, Capurro C.
    J Neurosci Res; 2012 Jun 04; 90(6):1240-8. PubMed ID: 22354518
    [Abstract] [Full Text] [Related]

  • 29. [A concept of neuromyelitis optica in Japan].
    Nakashima I, Fujihara K, Itoyama Y.
    Brain Nerve; 2010 Sep 04; 62(9):913-9. PubMed ID: 20844302
    [Abstract] [Full Text] [Related]

  • 30. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R, Saikali P, Vincent T.
    Ann N Y Acad Sci; 2009 Sep 04; 1173():478-86. PubMed ID: 19758189
    [Abstract] [Full Text] [Related]

  • 31. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G.
    Int J Neurosci; 2010 Jan 04; 120(1):71-5. PubMed ID: 20128675
    [Abstract] [Full Text] [Related]

  • 32. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B, Eger K, Kornhuber ME, Zierz S.
    Fortschr Neurol Psychiatr; 2008 Jan 04; 76(1):21-7. PubMed ID: 18189220
    [Abstract] [Full Text] [Related]

  • 33. [NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases].
    Zuliani L, López de Munain A, Ruiz Martínez J, Olascoaga J, Graus F, Saiz A.
    Neurologia; 2006 Jan 04; 21(6):314-7. PubMed ID: 16799907
    [Abstract] [Full Text] [Related]

  • 34. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population.
    Smith CH, Waubant E, Langer-Gould A.
    J Neuroophthalmol; 2009 Jun 04; 29(2):104-6. PubMed ID: 19491632
    [Abstract] [Full Text] [Related]

  • 35. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
    Ketelslegers IA, Modderman PW, Vennegoor A, Killestein J, Hamann D, Hintzen RQ.
    Mult Scler; 2011 Dec 04; 17(12):1527-30. PubMed ID: 21828202
    [Abstract] [Full Text] [Related]

  • 36. To test or not to test: NMO-IgG and optic neuritis.
    Giovannoni G.
    Neurology; 2008 Jun 03; 70(23):2192-3. PubMed ID: 18519868
    [No Abstract] [Full Text] [Related]

  • 37. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF.
    Arch Neurol; 2009 Aug 03; 66(8):964-6. PubMed ID: 19667216
    [Abstract] [Full Text] [Related]

  • 38. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG.
    Arch Neurol; 2008 Jan 03; 65(1):78-83. PubMed ID: 18195142
    [Abstract] [Full Text] [Related]

  • 39. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
    Mehta LR, Samuelsson MK, Kleiner AK, Goodman AD, Anolik JH, Looney RJ, Schwid SR.
    Mult Scler; 2008 Apr 03; 14(3):425-7. PubMed ID: 18208886
    [Abstract] [Full Text] [Related]

  • 40. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
    Yang Y, Huang DH, Wu L, Wu WP.
    Zhonghua Yi Xue Za Zhi; 2010 Mar 09; 90(9):606-9. PubMed ID: 20450783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.